MB "Teraflopsas" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
17,902 |
- |
4,990 |
4,759 |
- |
0.27 |
0.41 |
100.00 |
26.58 |
6,950 |
2,816 |
2,032 |
7,734 |
2023 |
---|
18,745 |
- |
962 |
913 |
- |
0.35 |
0.05 |
25.31 |
4.87 |
7,863 |
378 |
1,388 |
6,853 |
2024 |
---|
18,470 |
- |
834 |
792 |
- |
0.35 |
0.09 |
24.20 |
4.29 |
8,655 |
766 |
2,859 |
6,562 |
Register and
explore Okredo data2024 |
---|
18,470 |
- |
834 |
792 |
- |
0.35 |
0.09 |
24.20 |
4.29 |
8,655 |
766 |
2,859 |
6,562 |
Register and
explore Okredo data2024
Turnover (€)
18,470 €-1 % *
Sales per employee (€)
-Profit before tax (€)
834 €-13 % *
Net Profit (€)
792 €-13 % *
Profit per employee (€)
-Working capital requirement
0.35 0.00 % *
Debt-to-equity ratio
0.09 80.00 % *
Total profitability (%)
24.20 %-4.39 % *
Net profitability (%)
4.29 %-11.91 % *
Equity (€)
8,655 €10 % *
Amounts Payable And Liabilities (€)
766 €103 % *
Non-current Assets (€)
2,859 €106 % *
CurrentAssets (€)
6,562 €-4 % *